VALIPHARMA
Cronos Therapeutics, Ltd., a biopharmaceutical company, develops therapeutics and diagnostics based on epigenomics for the detection and treatment of cancer. Its GeneICE compounds represent a way of treating diseases by acting to shut down harmful genes and therefore prevent their expression. The company's HyperGenomics platform characterizes disease state by detecting areas on the chromosome where genes are active. Its compound, which is undergoing development, acts to shut down the Bcl-2 gene. Cronos Therapeutics, Ltd. was founded in 2004 and is based in London, the United Kingdom. As of October 3, 2006, Cronos Therapeutics Ltd. is a subsidiary of ValiRX PLC.
VALIPHARMA
Social Links:
Industry:
Biotechnology Health Diagnostics
Founded:
2004-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.valirx.com
Status:
Active
Contact:
+44 (0)203 0084415
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon WordPress Google Analytics Google Universal Analytics Sitelinks Search Box Yoast WordPress SEO Plugin Nginx Yoast Plugins
Similar Organizations
InnaVirVax
InnaVirVax develops therapeutics, diagnostics, prevention aids, and prognostics for HIV, infectious diseases, and cancers.
Precision Biologics
Precision Biologics develops therapeutic and diagnostic products for the early detection and treatment of cancer.
WILEX
WILEX is a biopharmaceutical company developing drugs and diagnostic agents to detect and treat malignant tumors and cancers.
Current Employees Featured
Official Site Inspections
http://www.valirx.com
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ValiPharma"
ValiRX - Crunchbase Company Profile & Funding
Valirx Plc, an investment holding company, engages in the research and …See details»
ValiRx plc (VAL.L) Company Profile & Facts - Yahoo Finance
See the company profile for ValiRx plc (VAL.L) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
ValiRx (AIM:VAL) Company Profile & Description - Stock Analysis
5 days ago ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company develops …See details»
Valirx Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 ValiRx, a biopharmaceutical company, engages in developing technologies and products in oncology therapeutics and diagnostics. Its proprietary GeneICE technology …See details»
ValiRx Org Chart + Executive Team - The Official …
Organizational Chart of ValiRx. ValiRx Org Chart www.valirx.com +44 203 008 4416; Add an executive. Latest news on ValiRx . Anything missing? …See details»
VALIRX PLC - LinkedIn
ValiRx PLC accelerates the development of innovative medicines that enhance patient experience. | VALIRX PLC is a biotechnology company …See details»
ValiRx Plc - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore ValiRx Plc with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 4 news, and 2 literature, Disease Domain:Neoplasms, Infectious Diseases, …See details»
ValiRx - VentureRadar
ValiRx is a biotechnology oncology focused company specialising in developing novel treatments for cancer and associated biomarkers. It aims to make a significant contribution in “precision” …See details»
Valirx - 2025 Company Profile, Funding & Competitors - Tracxn
Feb 27, 2025 Valirx is a biopharmaceutical company developing technologies and products in oncology therapeutics and diagnostics. Its lead programs include VAL201 (phase 1) which is a …See details»
VALIRX PLC Overview | SignalHire Company Profile
Its headquarters is located at London, England, GB. The number of employees ranges from 1 to 25. The VALIRX PLC annual revenue is estimated at < 1M. Total funding of the company - …See details»
ValiRx PLC. Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for ValiRx PLC.. See ValiRx PLC. company profile and funding data.See details»
Board & management team | ValiRx plc
Investor News & Media. Regulatory News Updates Reports, AGMs & Presentations Share Price Information AIM Rule 26 Analyst Research Webinars. About UsSee details»
ValiRx subsidiary Inaphaea agrees exclusive PredictRx licensing deal
1 day ago (Alliance News) - ValiRx PLC on Monday said subsidiary Inaphaea BioLabs has agreed an exclusive licensing deal with Dominion Biotech Ltd for Inaphaea's PredictRx …See details»
ValiPharma - Crunchbase Company Profile & Funding
Sub-Organization of . ValiRX . Operating Status Active. ... As of October 3, 2006, Cronos Therapeutics Ltd. is a subsidiary of ValiRX PLC. Read More . Phone Number +44 (0)203 …See details»
ValiRx New Evaluation and Option Agreement
Jan 29, 2025 ValiRx plc (the "Company") (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women's health, and Altus Formulation Inc ("Altus") a Canada …See details»
www.valirx.com
Www.valirx.com ... Redirecting...See details»
ValiRX - Contacts, Employees, Board Members, Advisors & Alumni
Organization. ValiRX . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Contacts 2. ... ValiRX …See details»
Our pipeline | ValiRx plc
Investor News & Media. Regulatory News Updates Reports, AGMs & Presentations Share Price Information AIM Rule 26 Analyst Research Webinars. About UsSee details»
Contact us | ValiRx plc
Investor News & Media. Regulatory News Updates Reports, AGMs & Presentations Share Price Information AIM Rule 26 Analyst Research Webinars. About UsSee details»
Strategy & vision | ValiRx plc
Investor News & Media. Regulatory News Updates Reports, AGMs & Presentations Share Price Information AIM Rule 26 Analyst Research Webinars. About UsSee details»